Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(2.14)
# 2,816
Out of 4,944 analysts
385
Total ratings
34.11%
Success rate
-2.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $435.24 | +30.96% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $4.38 | +813.24% | 17 | Aug 4, 2025 | |
| ATAI Atai Life Sciences | Maintains: Buy | $10 → $15 | $4.14 | +262.32% | 20 | Jul 30, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $3.85 | +211.69% | 18 | Jun 27, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $3.08 | +224.57% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $0.78 | +541.03% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.53 | +1,804.76% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.78 | +1,197.58% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $33.17 | +201.52% | 21 | Jun 2, 2025 | |
| QURE uniQure | Reiterates: Buy | $70 | $14.78 | +373.61% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.05 | +376.19% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.44 | +1,252.87% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $19.65 | +307.12% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $13.05 | +206.51% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.69 | +713.01% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $36.30 | +92.84% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $17.62 | +354.03% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.71 | +486.51% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.96 | +411.51% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $9.92 | +454.44% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $4.52 | +2,333.63% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $40.83 | +108.18% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $7.51 | +1,898.67% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.51 | +443.57% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $176.80 | +92.31% | 1 | Aug 18, 2021 |
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $435.24
Upside: +30.96%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $4.38
Upside: +813.24%
Atai Life Sciences
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.14
Upside: +262.32%
Altimmune
Jun 27, 2025
Reiterates: Buy
Price Target: $12
Current: $3.85
Upside: +211.69%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $3.08
Upside: +224.57%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $0.78
Upside: +541.03%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.53
Upside: +1,804.76%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $5.78
Upside: +1,197.58%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $33.17
Upside: +201.52%
uniQure
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $14.78
Upside: +373.61%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.05
Upside: +376.19%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.44
Upside: +1,252.87%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $19.65
Upside: +307.12%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $13.05
Upside: +206.51%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.69
Upside: +713.01%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $36.30
Upside: +92.84%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $17.62
Upside: +354.03%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.71
Upside: +486.51%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $1.96
Upside: +411.51%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $9.92
Upside: +454.44%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $4.52
Upside: +2,333.63%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $40.83
Upside: +108.18%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $7.51
Upside: +1,898.67%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.51
Upside: +443.57%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $176.80
Upside: +92.31%